Information Provided By:
Fly News Breaks for August 10, 2017
IPXL
Aug 10, 2017 | 07:19 EDT
UBS analyst Marc Goodman acknowledged Impax reported good Q2 results, but he believes the share price is ahead of itself. He said investors still own the stock in anticipation of a creative, value-additive transaction, but the analyst feels such a scenario is already priced into the valuation. He also feels skeptical of the company's near-term growth drivers, as they too are already in the stock's valuation. Goodman reiterated his Sell rating and $12 price target on Impax shares.
News For IPXL From the Last 2 Days
There are no results for your query IPXL